Navigation Links
Naviscan® Announces Collaboration With Neoprobe Corporation to Enable Pipeline Technology Development
Date:2/24/2011

SAN DIEGO, Feb. 24, 2011 /PRNewswire/ -- Naviscan, Inc. announced that it has entered into an exclusive licensing agreement with Neoprobe Corporation (NYSE Amex: NEOP) as a partner to further develop its patented imaging technology.  While most of the patents in Naviscan's extensive intellectual property portfolio were designed to enable innovation in organ-specific molecular imaging, several more recently-allowed patents were devised to further broaden the company's product base. One such patent, now licensed to Neoprobe, enables a novel gamma ray detector, or a gamma probe, to translate gamma emission data into a 3-dimensional representation of a gamma-emitting source, such as a malignant lesion or tumor.

Maintaining its lead in the field of Molecular Breast Imaging, Naviscan continues to devote its resources to commercializing its current PET scanner and biopsy-guidance accessories, both optimized for breast imaging, and expanding its platform to other applications (e.g. head, neck, extremities, etc.).  Partnering with Neoprobe, a leader in 3-D gamma imaging, allows Naviscan technology to be developed in cancer surgical applications.

"Our expanding patent portfolio continues to strengthen our clinically-relevant, technology leadership while creating opportunities to build strategic partnerships, monetize our intellectual properties and, in turn, increase the company's valuation.  Toward that end, this licensing agreement provides an opportunity for Naviscan to work with a proven development partner in the gamma detection instrumentation space with a strong record of commercialization success," said Paul Mirabella, Chairman and CEO of Naviscan, Inc. "Neoprobe's competencies and resources are well-suited to build upon our 3-dimensional molecular imaging technology and realize its full value."  

"Our agreement with Naviscan provides an oppor
'/>"/>

SOURCE Naviscan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. West Appoints Two Directors and Announces Second Quarter 2011 Dividend
2. Video from Lundbeck available on thenewsmarket.com: Lundbeck Announces 2010 Results: Meet all Financial Expectations
3. Mindray Announces FDA 510(k) Clearance of Its A5 Anesthesia System
4. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
5. OrthoAccel Technologies, Inc. Announces New Scientific Advisor
6. Regeneron Announces March 2011 Investor Conference Presentations
7. Generex Announces New Treatment IND Site for the USFDA Expanded Access Treatment IND Program for Generex Oral-lyn™ in the United States
8. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
9. Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension
10. Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance
11. MonoSol Rx, LLC Announces Suboxone Sublingual Film Achieves 25% Share of Total U.S. Suboxone Market Volume at Year-End 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 3, 2015  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: ... on its expertise in opioid antagonists, announced today ... treating opioid overdose with intranasal naloxone, has commenced ... (NDA) to the United States Food and Drug ... naloxone, a drug intended to treat opioid overdose. ...
(Date:6/3/2015)...  The International Confederation of Midwives (ICM) has provided ... a standard for midwives trained to ICM,s competency standards.  ... consultation with ICM experts. Direct Relief will provide the ... As many as one in 30 women ... childbirth.  Skilled birth attendants such as midwives offer the ...
(Date:6/3/2015)... 2015 According to a ... Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, ... IVC Filters, Stents, Balloons and Accessories) - Forecasts ... and Peripheral Vascular Devices Market is expected to ... CAGR of 7.4% from 2014 to 2019. ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 3A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 4The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 3The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 4
... Dec. 29, 2011 BioDelivery Sciences International, Inc. (Nasdaq: ... announcement by the U.S. Food and Drug Administration (FDA) ... transmucosal fentanyl products has been approved.  The program, which ... Fentanyl (TIRF) REMS Access Program, was designed to ensure ...
... ESRX ) announced that it will present at ... 2012 at 9:00 a.m. PST (12:00 p.m. EST) at the ... The presentation will also be broadcast via the Internet and ... Scripts web site at http://www.express-scripts.co m .  RealPlayer ...
Cached Medicine Technology:ONSOLIS to Benefit from Approval of Class-Wide REMS for All Transmucosal Fentanyl Products 2ONSOLIS to Benefit from Approval of Class-Wide REMS for All Transmucosal Fentanyl Products 3ONSOLIS to Benefit from Approval of Class-Wide REMS for All Transmucosal Fentanyl Products 4
(Date:6/3/2015)... (PRWEB) June 03, 2015 A ... additional precautions on product labels underscores the importance ... according to the American Society for Dermatologic Surgery ... include new warnings about the risks for serious ... vessels. While product labels already include information about ...
(Date:6/3/2015)... Loma Linda University Health and Adventist ... Gorgonio Memorial Hospital (SGMH). The SGMH board voted unanimously ... , “Loma Linda University Health has been serving the ... executive officer, Loma Linda University Medical Center. “We are ... to this community.” , Under the proposed affiliation, ...
(Date:6/3/2015)... June 03, 2015 Johnson & Johnson ... $7.8 million to resolve a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ... the company allegedly used to market the antipsychotic drug. ... indicate that the Arkansas Attorney General moved to dismiss ... accord. The Risperdal settlement amounts to just a fraction ...
(Date:6/3/2015)... DC (PRWEB) June 03, 2015 The ... to announce that Maria C. Savoia, M.D., Dean of Medical ... of Medicine, will become Chair on July 1. ... Chair of the National Resident Matching Program,” said Dr. Savoia. ... reliable process for matching medical students with training programs, and ...
(Date:6/3/2015)... On the heels of a report predicting ... 2020 ( click here to review news coverage about ... Baltimore has the talent to become a world-leading center ... and other biological data are collected and analyzed to help ... all the elements of a perfect storm for bioinformatics leadership,” ...
Breaking Medicine News(10 mins):Health News:ASDSA Supports FDA Fillers Directive 2Health News:ASDSA Supports FDA Fillers Directive 3Health News:ASDSA Supports FDA Fillers Directive 4Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3
... stage III colon cancer treated with 5-FU-based chemotherapy after ... improved overall survival with no change in time to ... patients with stage II colon cancer treated after 1995 ... to death compared to those patients treated prior to ...
... ... Days of Intentions to mark the mid-point of 2010. , ... Los Angeles, CA (PRWEB) June 3, 2010 -- This week, Intent.com launches ... Days of Intentions is a challenge to the internet community to commit to posting one new ...
... Davis public health researchers have found that children, who ... choices, are the targets of a new medium used ... an entertaining blend of interactive animation, video content and ... online messages that primarily promote corporate branding and products. ...
... high school, study finds , THURSDAY, June 3 (HealthDay News) ... the two years following high school are less likely to ... , The finding builds on past research that had demonstrated ... and alcohol abuse. , "I,m not saying that we should ...
... but others say it,s not always that simple, , THURSDAY, ... prompts anxiety in many a parent. But having to ... story can make an already sensitive subject even more complicated. ... parents. , As assisted reproduction technology, in which someone other ...
... ... ... 2010 -- Thomas D. Meade, M.D., a nationally renowned knee specialist who has performed ... June 1, Dr. Meade will see patients at Coordinated Health facilities in Allentown, Bethlehem, ...
Cached Medicine News:Health News:Stage II and stage III colon cancer patients treated after 1995 have improved overall survival 2Health News:Intent.com Launches 30 Days of Intentions and Announces Winners of 2010 Intent Web Awards 2Health News:Online games new marketing tool for unhealthy foods 2Health News:Online games new marketing tool for unhealthy foods 3Health News:Romance May Steer Young Adults Away From Booze, Pot 2Health News:Donor-Assisted Conception Sparks Disclosure Dilemmas 2Health News:Donor-Assisted Conception Sparks Disclosure Dilemmas 3Health News:Nationally Renowned Knee Specialist Dr. Thomas Meade Joins Coordinated Health 2Health News:Nationally Renowned Knee Specialist Dr. Thomas Meade Joins Coordinated Health 3
The PowerLab/4ST is a high-performance recording unit with built-in amplifiers and is suitable for physiology teaching. It has been designed to cover the broad experimental requirements in life scien...
... data acquisition system suitable for a wide ... animal physiology, pharmacology, neurophysiology, biology, zoology, biochemistry, ... of recording from very slow to very ... per second continuously to disk), and is ...
Worth 4-Dot Flashlight/Plastic for testing and training of visual functions and testing for fusion, suppression and/or diplopia. Red/green goggle included. Requires 2 C batteries (not included)....
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
Medicine Products: